Cargando…

Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis

BACKGROUND: Multi-drug resistance among Acinetobacter baumannii increases the need for polymyxins. We conducted a meta-analysis aimed to assess the efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection. METHODS: We searched PUBMED, EMBASE, the Cochrane Central Regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qianqian, Li, Wenzhang, Feng, Yulin, Tao, Chuanmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049575/ https://www.ncbi.nlm.nih.gov/pubmed/24911658 http://dx.doi.org/10.1371/journal.pone.0098091

Ejemplares similares

Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study
por: Pan, Sijun, et al.
Publicado: (2018)

Correction to: Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study
por: Pan, Sijun, et al.
Publicado: (2019)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
por: Lyu, Cheng, et al.
Publicado: (2020)

Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
por: Liu, Qianqian, et al.
Publicado: (2015)

Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China
por: Liu, Qianqian, et al.
Publicado: (2015)

The association of interleukin-10 -1082, -819, -592 polymorphisms and tuberculosis risk
por: Liu, Qianqian, et al.
Publicado: (2015)

Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis
por: Yang, Ping, et al.
Publicado: (2023)

Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
por: Ni, Wentao, et al.
Publicado: (2015)

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

Polymyxins–Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
por: Dai, Chongshan, et al.
Publicado: (2020)

Performance of interferon-γ release assay in the diagnosis of tuberculous lymphadenitis: a meta-analysis
por: Liu, Qianqian, et al.
Publicado: (2017)

Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis
por: Lu, Difan, et al.
Publicado: (2023)

Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis
por: Liu, Qianqian, et al.
Publicado: (2017)

A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
por: Park, Jaeeun, et al.
Publicado: (2021)

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2016)

Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
por: Xia, G. L., et al.
Publicado: (2021)

Editorial Commentary: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed
por: Pogue, Jason M., et al.
Publicado: (2015)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
por: Chauzy, Alexia, et al.
Publicado: (2022)

Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature
por: Zhong, Li, et al.
Publicado: (2020)

Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections
por: Lu, Xin, et al.
Publicado: (2022)

Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B’s Effects
por: Lu, Yun, et al.
Publicado: (2021)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis
por: Samal, Samir, et al.
Publicado: (2021)

Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature
por: Li, Ziyu, et al.
Publicado: (2022)

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance
por: Zhu, Yan, et al.
Publicado: (2020)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
por: Wences, Marisol, et al.
Publicado: (2022)

Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug–Resistant Acinetobacter baumannii Infections: A Drug Pair Limiting the Development of Resistance
por: Wang, Junwei, et al.
Publicado: (2023)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus Complex
por: Garcia, Rebeca Carvalho Lacerda, et al.
Publicado: (2023)

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
por: Guo, Wei, et al.
Publicado: (2018)

Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
por: Sato, Yoshinori, et al.
Publicado: (2018)

Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii
por: Chung, Joon-hui, et al.
Publicado: (2016)

Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
por: Tran, Thien B., et al.
Publicado: (2015)

Parenteral polymyxins: Assessing efficacy and safety in critically ill patients with renal dysfunction
por: Sekhri, Kavita, et al.
Publicado: (2013)

Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
por: Zhu, Yan, et al.
Publicado: (2019)

Efficacy and nephrotoxicity of polymyxin B in elderly patients with carbapenem resistant bacterial infection
por: Xia, G. L., et al.
Publicado: (2023)

Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii: a meta-analysis
por: Zhang, Huagen, et al.
Publicado: (2015)

Oral doxycycline to carbapenem-resistant Acinetobacter baumannii infection as a polymyxin-sparing strategy: results from a retrospective cohort
por: Tuon, Felipe Francisco, et al.
Publicado: (2023)

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
por: Chu, Haiqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_moc8q6dt4urhhfj2stpqp0hbqi